Alts Watch Healthcare Beat

RNA-based therapies and data platforms geared toward oncology treatment are among the deals done in this week’s installment of the Alts Watch Healthcare Beat. The partnership, two PIPEs and other financing deals totaled over $500 million, according to our tally ...

New treatments for cancer, rheumatoid arthritis and diabetes are on the horizon thanks to a series private capital deals over the past week. Alternative investment firms leading the way were: H.I.G. Capital; BlackRock; Surveyor Capital (a Citadel company); New Enterprise ...

Hedge funds, private equity firms, leading sovereign wealth funds and pensions this past week marched into emerging healthcare technologies that are preparing to go to market with revolutionary treatments. Roughly $2.3 billion flowed via 16 financing deals for the week ...

For the week ending January 10, Alternatives Watch has tracked more than $1.8 billion in private financing deals done by private equity firms, institutional investors and hedge funds in the life sciences arena. Some of the more well-known investors this ...

Farallon Capital Management, Millennium Management, Magnetar and Ziff Capital are among the growing number of hedge funds, private equity firms and mutual fund companies investing in private placement rounds with biotech startups in this week's Alts Watch Healthcare Beat. We ...

As a revolutionary year in healthcare comes to a close, investors piled $2 billion into AI-driven therapeutics, digital health and other life sciences-focused technologies over the past week. Investors in various rounds of financing include top-names in venture capital, private ...

In numerical terms, our latest recon of private market investment in the life sciences is about on par with the previous week: 13 deals with a total value of $987 million. But there was a noticeable difference on the focus ...

If anything could put a damper on the red-hot private market activity in healthcare, the Thanksgiving holiday did -- so much so that we didn't publish the Alts Watch Healthcare Beat (AWHB) roundup last week. Our combined two-week recon tallied ...

One deal towers above the rest in our look at the $1.41 billion private capital activity in healthcare for the week of Nov. 16-20. After operating as the venture capital arm of UK pharmaceutical giant GlaxoSmithKline (GSK) since 1985, SR ...

No, you're not imagining it: private equity investment in healthcare has been on the rise. In fact, Pitchbook data shows the number of PE healthcare deals in the U.S. more than doubled between 2008 and 2018 to a total of ...